CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Amount	Additional paid in capital	Retained earnings (accumulated deficit)	Accumulated other comprehensive income (loss)	Treasury stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding (in shares)	1,940,687
Beginning balance at Dec. 31, 2021	$ 24,412	$ 0	$ 33,277	$ 7,708	$ 2,342	$ (18,915)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Charge related to stock-based compensation	$ 78		78
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture	6,072
Conversion of Stock, Shares Issued	11,334
Treasury Stock, Value, Acquired, Cost Method	$ (1,982)		0			(1,982)
Release of restricted stock	$ 0		(75)			75
Treasury Stock, Shares, Acquired	99,293
Prior Period Reclassification Adjustment	$ 23				23
Foreign currency translation	(2,546)				(2,546)
Pension obligations, net of tax of $10	19				19
Issuance of unrestricted shares	240		97			143
Net loss	(4,490)			(4,490)
Dividends, Common Stock, Cash	(1,532)			(1,532)
Ending balance at Dec. 31, 2022	$ 14,176	0	33,377	1,686	(208)	(20,679)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding (in shares)	1,858,800
Charge related to stock-based compensation	$ 43		43
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture	12,808
Repurchase of common stock	$ 12		(35)			47
Conversion of Stock, Shares Issued	2,000
Treasury Stock, Value, Acquired, Cost Method	$ (176)		0			(176)
Treasury Stock, Shares, Acquired	(13,454)
Foreign currency translation	$ (819)				(819)
Pension obligations, net of tax of $10	12				12
Issuance of unrestricted shares	223		(76)			299
Net loss	(2,239)			(2,239)
Dividends, Common Stock, Cash	(748)			(748)
Ending balance at Dec. 31, 2023	$ 10,484	$ 0	$ 33,309	$ (1,301)	$ (1,015)	$ (20,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares outstanding (in shares)	1,860,154